Online: July 13 2021
Online: August 28-31 2021
Online: June 22 2021
Online: 23 May-22 July 2021 & In person: 21-24 June 2021
In person: 2-4 July 2021
Online: August 1-4 2021
In person: 4-17 August 2021
In person: October 17-20 2021
In person: November 28 - December 2 2021
In person: November 16-20 2021
The University of Michigan implemented a new NGS capture-based solution to assess myeloid malignancies.
Whole-exome sequencing has emerged as a comprehensive and cost-effective tool for researching rare disease-causing variants.
The SOPHiA DDM™ platform unlocks the power of new-generation health data for cancer and rare disease management.
A major challenge in precision medicine is quick, reliable identification of potentially disease-causing genetic variants.